Histologic Phenotype |
○ Pure small-cell prostate cancer |
○ Mixed small-cell prostate cancer |
○ Subtypes classified per WHO 2016 and PCF classification |
Tumor Markers |
○ CgA |
○ synaptophysin |
○ CD56 |
○ NSE |
Presentation |
○ De novo |
○ Emerging in castration resistant patients following ADT |
Clinical course |
○ Aggressive, poor prognosis |
○ Treatment-emergent subtype: predominantly lytic/visceral metastases, bulky tumor masses, low PSA |
○ Unresponsive to androgen targeted therapies |
○ Short-lived response to platinum-based chemotherapy |